← Leaderboards
Joelle Payne Straehla
Dana-Farber Cancer Inst
$461,894
Attributed
$461,894
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $230.9K · FY2024–25$250K$187.5K$125K$62.5K$0
'24
'25
Funding mix
By agency
NIH$461,894 · 1
By mechanism
K08$461,894 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Birgit Knoechel$3,667,430
- Rochelle Bagatell$1,843,838
- Yana Pikman$885,600
- Gregory Howard Bird$3,139,726
- Kira O. Bona$1,544,325
Others in their field
Other Rising Stars on “Advisory Committees”
- Brian Zavertnik · Palantir Technologies, Inc.$33,059,912
- Johanna Marizan-Ho · Palantir Technologies, Inc.$9,612,691
- Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
- Brian Todd Schaneberg · Illinois Institute Of Technology$6,784,113
- Burton Rochelson · Feinstein Institute For Medical Research$5,891,324
- Christine O'Connell · H. Lee Moffitt Cancer Ctr & Res Inst$5,494,823
Research focus
Advisory CommitteesAnabolismAnti-Cancer ResearchAntineoplastic AgentsAreaAwardBiological MarkersBiological ModelsBostonCancer BiomarkersCancer CellCancer Cell LineCancer PatientCancer TherapyCareerCell LineCellsCharacteristicsChildhoodClinicClinical BiomarkersClinical StratificationClinical TrialsAcceleration
Grant awards (3)
Investigating SLC46A3 as a negative regulator of nanoparticle drug delivery$230,947
K08 · FY2025 · CA · contact PI
Investigating SLC46A3 as a negative regulator of nanoparticle drug delivery$230,946
K08 · FY2024 · CA · contact PI
Investigating SLC46A3 as a negative regulator of nanoparticle drug delivery$1
K08 · FY2024 · CA · contact PI